- PLATELET ADP RECEPTOR INHIBITORS
-
Compounds are provided which are useful as platelet ADP receptor inhibitors, for treating thrombosis and for reducing the likelihood and/or severity of a secondary ischemic event in a patient.
- -
-
Page/Page column 33
(2008/06/13)
-
- VIRAL POLYMERASE INHIBITORS
-
Compounds of formula (I): wherein X, R2, R3, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.
- -
-
Page/Page column 63
(2010/11/28)
-
- 2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use
-
Selected compounds are effective for treatment of diseases, such as cell proliferation or apoptosis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving stroke, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
- -
-
-